Femasys Inc.
PublicFemasys Inc. is now publicly traded
The data on this page reflects Femasys Inc.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Jun 17, 2021
Last Round
Private Placement
Aug 20, 2026
Total Funding Raised
$138M
Company Overview
Femasys Inc. is a biomedical company that develops and commercializes therapeutic and diagnostic products for women's reproductive health needs.
AI Layer
Non-AI
Keywords
Femasys Inc. Comparables
Compare Femasys Inc. with similar companies based on industry and business-model similarity.
No public comparables are available for Femasys Inc.. Request access to learn about comparables coverage.
Request accessFemasys Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Aug 20, 2026 | ||||
| Follow-on Offering | Sep 2, 2025 | ||||
| Private Placement | Jun 2, 2025 | ||||
| Convertible Debt | Nov 15, 2023 | ||||
| IPO | Jun 17, 2021 | ||||
Series C Extension | Jan 6, 2017 |
Key People
Founding team and executive leadership
Femasys Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| JonesTrading | Private Placement |
| Rosalind Advisors | Private Placement |
| Salem Partners | Series C Extension, Series B, Series C |
| Chardan | IPO |
| Nantahala Capital Management | Private Placement |
Femasys Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access